Aurora Cannabis is a medical marijuana producer.Aurora is committed to providing all of its patients with the highest standard of product quality, customer service, and affordable pricing.
Golden Leaf Holdings is a fast growing company and leading cannabis oil solutions company built around recognized brands. Golden Leaf Holdings is one of the largest cannabis oil and solution providers in North America and is a leading cannabis company in Oregon. With a product portfolio built around recognized brands, the Company strives to provide cannabis users with superior value and experience. We leverage a strong management team and advanced research techniques that complement our expertise in extracting, refining, marketing, and selling cannabis oil. Firmly committed to operational transparency and tight controls, Golden Leaf Holdings demonstrates its resolve to be an industry leader and a partner to communities and regulators
Gage Cannabis Co. is innovating and curating the highest quality cannabis experiences possible for cannabis consumers in the state of Michigan and bringing internationally renowned brands to market.
Mind Medicine Inc. is a biopharmaceutical company focused on discovering, developing, and deploying psychedelic-inspired medicines and therapies aimed at addressing addiction and mental health issues. Headquartered in New York, the company is building a diverse drug development pipeline that includes innovative treatments derived from psychedelic substances such as Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative known as 18-MC. Founded in 2010 by JR Rahn, Scott Freeman, Leonard Latchman, and Stephen L. Hurst, MindMed is actively engaged in forming collaborations and conducting clinical trials to further explore the therapeutic potential of these substances in treating brain health disorders.
Mind Medicine Inc. is a biopharmaceutical company focused on discovering, developing, and deploying psychedelic-inspired medicines and therapies aimed at addressing addiction and mental health issues. Headquartered in New York, the company is building a diverse drug development pipeline that includes innovative treatments derived from psychedelic substances such as Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative known as 18-MC. Founded in 2010 by JR Rahn, Scott Freeman, Leonard Latchman, and Stephen L. Hurst, MindMed is actively engaged in forming collaborations and conducting clinical trials to further explore the therapeutic potential of these substances in treating brain health disorders.
Curaleaf is a leading vertically integrated medical and wellness cannabis operator.
Avicanna Inc. is a biopharmaceutical company based in Toronto, Canada, specializing in the research, development, cultivation, and commercialization of plant-derived cannabinoid-based products for medical and consumer health markets globally. The company offers a range of pharmaceutical-grade cannabinoids, including THC, CBD, and CBG, alongside active pharmaceutical ingredients and feminized seeds, marketed under the Aureus Santa Marta brand. Avicanna also develops CBD-based derma-cosmetic products under the Pura Earth brand and medical cannabis solutions for various health conditions, including skin disorders and neurological issues, marketed under the Rho Phyto brand. The company emphasizes an evidence-based approach and engages in strategic collaborations with research institutions to advance its cannabinoid solutions. Notably, Avicanna is involved in research aimed at developing cannabinoid-based pharmaceuticals for conditions such as COVID-19 induced lung inflammation. Founded in 2016, Avicanna has positioned itself as a key player in the international cannabinoid market.
AYR Wellness aims higher for the wellness of our customers, through the power of cannabis. We grow and sell the highest-quality cannabis products available anywhere, inspiring wellness and wonder in our customers, wherever they are on their cannabis journey. We operate with a sense of responsibility to our customers and patients, building stronger and more socially responsible communities everywhere we go.
OrganiGram Holdings Inc is a Licensed Producer of medical marijuana in Canada, operating under the Marihuana for Medical Purposes Regulations (MMPR). The company specializes in producing indoor-grown cannabis, catering to both medical patients and adult recreational consumers. OrganiGram has established a diverse portfolio of recreational cannabis brands, including Edison, Big Bag o' Buds, SHRED, Monjour, Holy Mountain, and Trailblazer. Recently, it has expanded its offerings with the addition of Tremblant Cannabis and the artisanal craft brand Laurentian, further enhancing its brand portfolio. The company's commitment is to provide high-quality cannabis products and services to its clients.
4Front is a cannabis company designed for long-term success and built upon battle-tested operating capabilities at scale, experienced and committed leadership, a strategic asset base, and a commitment to being a magnet for talent. From plant genetics to the cannabis retail experience, 4Front’s team applies expertise across the value chain. 4Front has invested to assemble a comprehensive collection of management skills and hands-on operating expertise to capitalize on the unique growth opportunity being afforded by the increased legalization of cannabis. It was founded in 2011 and headquartered in Phoenix, Arizona.
Mind Medicine Inc. is a biopharmaceutical company focused on discovering, developing, and deploying psychedelic-inspired medicines and therapies aimed at addressing addiction and mental health issues. Headquartered in New York, the company is building a diverse drug development pipeline that includes innovative treatments derived from psychedelic substances such as Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative known as 18-MC. Founded in 2010 by JR Rahn, Scott Freeman, Leonard Latchman, and Stephen L. Hurst, MindMed is actively engaged in forming collaborations and conducting clinical trials to further explore the therapeutic potential of these substances in treating brain health disorders.
Mind Medicine Inc. is a biopharmaceutical company focused on discovering, developing, and deploying psychedelic-inspired medicines and therapies aimed at addressing addiction and mental health issues. Headquartered in New York, the company is building a diverse drug development pipeline that includes innovative treatments derived from psychedelic substances such as Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative known as 18-MC. Founded in 2010 by JR Rahn, Scott Freeman, Leonard Latchman, and Stephen L. Hurst, MindMed is actively engaged in forming collaborations and conducting clinical trials to further explore the therapeutic potential of these substances in treating brain health disorders.
Tetra Bio-Pharma Inc. is a development stage biopharmaceutical company based in Orleans, Canada, specializing in cannabinoid-based medicines. The company focuses on developing treatments for chronic pain, with several drugs in its pipeline, including SERENITY for cancer cachexia and REBORN for breakthrough pain, both in clinical phase 2, and PLENITUDE for advanced cancer pain, currently in clinical phase 1. Additionally, Tetra Bio-Pharma is developing PPP003 for painful dry eye and uveitis pain, also in clinical phase 1, along with HCC011 for hepatocellular carcinoma. The company has established collaboration agreements with various organizations, including Aphria Inc. and the University of New Brunswick, and has a co-development partnership with Storz & Bickel for fibromyalgia treatment. Tetra Bio-Pharma was previously known as GrowPros Cannabis Ventures Inc. before rebranding in September 2016.
Cardiol Therapeutics Inc. is a clinical-stage life sciences company based in Oakville, Canada, specializing in the development of pharmaceutical cannabidiol (CBD) products and innovative therapies for heart diseases, including acute myocarditis and heart failure. The company's flagship product, CardiolRx, is a pharmaceutically formulated oral CBD designed for clinical applications in treating heart conditions. Additionally, Cardiol Therapeutics is working on advanced nanotechnology to facilitate targeted delivery of CBD and other anti-inflammatory drugs directly to inflamed areas of the heart. The company has received authorization from the United States Food and Drug Administration to conduct clinical studies assessing the efficacy and safety of CardiolRx in various heart diseases, including participation in the Phase II multi-national ARCHER trial. This focus on both cannabinoid-based and anti-inflammatory therapies positions Cardiol Therapeutics at the forefront of addressing significant medical needs in cardiology.
Harvest Health and Recreation Inc. (CSE:HARV), is a consistently profitable, vertically integrated cannabis company with one of the largest footprints in the world. Harvest’s industry-leading cultivation, manufacturing, retail facilities, construction, real estate and technologies are backed by experienced, in-house finance, compliance, operations, real estate, human resources, marketing and legal teams, who have a proven and trusted track record in the cannabis industry.
Brains Bioceutical Corp. engages in the production of naturally-sourced active pharmaceutical ingredients (API) for the pharmaceutical and nutraceutical industries. The company offers CBD oil, capsules, balm, and spray. It serves pharmaceutical; health and wellness; skin and beauty; and veterinary sectors. The company is based in Vancouver, Canada.
Green Growth Brands is a lifestyle-oriented, consumer products company that celebrates health, wellness, and happiness. It brings together a collection of retailers, scientists, botanists, developers, artists, and business leaders. The company was founded in 2018 and is headquartered in Ohio.
Aleafia Health is a vertically integrated cannabis company focused on providing medical cannabis care to Canadians. The company operates a national network of clinics and has served over 60,000 patients, ensuring access to effective treatments under Health Canada's regulations. Aleafia Health owns three cannabis cultivation and product facilities, producing a diverse range of high-margin derivative products, including oils, capsules, and sprays. The company emphasizes the importance of standardized, pesticide-free cannabis and leverages historical data to support physicians in making informed recommendations, thereby enhancing patient care and outcomes. Through its commitment to innovation in cannabis health and wellness products and services, Aleafia Health aims to improve the quality of life for its patients.
Cansortium utilizes a unique combination of capital and expertise in making strategic investments to help launch mature and professional cannabis markets. As global regulations evolve, Consortium Holdings is well-positioned to expand its presence in the U.S. and Puerto Rico. The company was founded in 2016.
Quinsam Capital Corporation is an investment and merchant banking firm based in Toronto, Canada, specializing in the small-cap market with a particular emphasis on cannabis-related investments. Founded in 2004, the firm engages in various activities, including acquisitions, advisory services, lending, and portfolio investments. Quinsam focuses on investing in assets, companies, or projects that are perceived as undervalued, with the intention of implementing strategies to unlock their potential value. Although primarily operating in Canada, Quinsam also has an international presence in its merchant banking endeavors.
The Tinley Beverage Company Inc. manufactures and sells liquor-inspired, non-alcoholic, and cannabis-infused beverages in the United States. It also offers Tinley Tonic and Tinley 27 line of products through retail locations in California; and online in the United States. The company was formerly known as Quia Resources Inc. and changed its name to The Tinley Beverage Company Inc. in October 2015. The Tinley Beverage Company Inc. was incorporated in 2007 and is based in Toronto, Canada.
OrganiGram Holdings Inc is a Licensed Producer of medical marijuana in Canada, operating under the Marihuana for Medical Purposes Regulations (MMPR). The company specializes in producing indoor-grown cannabis, catering to both medical patients and adult recreational consumers. OrganiGram has established a diverse portfolio of recreational cannabis brands, including Edison, Big Bag o' Buds, SHRED, Monjour, Holy Mountain, and Trailblazer. Recently, it has expanded its offerings with the addition of Tremblant Cannabis and the artisanal craft brand Laurentian, further enhancing its brand portfolio. The company's commitment is to provide high-quality cannabis products and services to its clients.
Quinsam Capital Corporation is an investment and merchant banking firm based in Toronto, Canada, specializing in the small-cap market with a particular emphasis on cannabis-related investments. Founded in 2004, the firm engages in various activities, including acquisitions, advisory services, lending, and portfolio investments. Quinsam focuses on investing in assets, companies, or projects that are perceived as undervalued, with the intention of implementing strategies to unlock their potential value. Although primarily operating in Canada, Quinsam also has an international presence in its merchant banking endeavors.
OrganiGram Holdings Inc is a Licensed Producer of medical marijuana in Canada, operating under the Marihuana for Medical Purposes Regulations (MMPR). The company specializes in producing indoor-grown cannabis, catering to both medical patients and adult recreational consumers. OrganiGram has established a diverse portfolio of recreational cannabis brands, including Edison, Big Bag o' Buds, SHRED, Monjour, Holy Mountain, and Trailblazer. Recently, it has expanded its offerings with the addition of Tremblant Cannabis and the artisanal craft brand Laurentian, further enhancing its brand portfolio. The company's commitment is to provide high-quality cannabis products and services to its clients.
Origin House is a cannabis product and brands company based in Ottawa, Canada, with a significant presence in key markets across the United States and Canada. Founded in 2015, the company focuses on becoming a leading global house of cannabis brands. Origin House delivers over 130 branded cannabis products to licensed dispensaries, primarily in California, which is the largest regulated cannabis market. The company offers a comprehensive suite of services, including distribution, manufacturing, cultivation, and marketing, to support its brand partners. It operates through two segments: one that generates income from non-operating investments and another that is involved in cultivation, manufacturing, and distribution activities. Origin House aims to capitalize on opportunities in the growing legal cannabis sector, with an emphasis on acquisitions and majority stakes in companies.